bioAffinity Technologies, Inc. (BIAF) Balance Sheet
BIAF balance sheet, 2025
December 31, 2025 · U.S. dollars$11.0M assets = $3.7M liabilities + $7.3M equity
Both columns are drawn to the same scale: what BIAF owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BIAF financial health
Descriptive bands, not a rating. Fiscal 2025.
BIAF balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $658,8102019 | $11.0M2025 | +59.8%/yr | |
| Total liabilities | $4.7M2019 | $3.7M2025 | −4.0%/yr | |
| Shareholders’ equity | −$4.0M2019 | $7.3M2025 | — | |
| Cash & short-term investments | $578,4832019 | $6.4M2025 | +49.5%/yr | |
| Total debt | $4.0M2019 | $1.2M2025 | −18.7%/yr | |
| Net cash (debt) | −$3.4M2019 | $5.3M2025 | +$8.7M | |
| Working capital | −$4.1M2019 | $4.7M2025 | +$8.7M | |
| Current ratio | 0.132019 | 2.602025 | +2.47 | |
| Debt / equity | 0.022022 | 0.162025 | +0.14 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BIAF assets
BIAF liabilities and equity
BIAF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BIAF balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $6.4M | $1.1M | $2.8M | $11.4M | $1.4M | $83,108 | $578,483 |
| Cash & equivalents | $6.4M | $1.1M | $2.8M | $11.4M | $1.4M | $83,108 | $578,483 |
| Receivables | $541,962 | $1.1M | $811,674 | $10,489 | $1,530 | $1,530 | $1,530 |
| Inventory | $53,548 | $27,608 | $18,484 | $5,540 | $71,846 | $28,352 | $0 |
| Other current assets | $519,916 | $422,995 | $321,017 | $531,899 | $4,219 | $5,665 | $37,493 |
| Total current assets | $7.6M | $2.7M | $4.0M | $12.0M | $1.4M | $118,655 | $617,506 |
| Property, plant & equipment (net) | $1.3M | $1.6M | $2.0M | $214,438 | $4,633 | $9,450 | $28,804 |
| Goodwill & intangible assets | $2.1M | $2.2M | $2.2M | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $12,815 | $19,676 | $16,060 | $6,000 | $10,442 | $17,500 | $12,500 |
| Total assets | $11.0M | $6.5M | $8.2M | $12.2M | $1.5M | $145,605 | $658,810 |
| Liabilities | |||||||
| Accounts payable | $761,901 | $987,311 | $604,789 | $345,042 | $230,407 | $191,387 | $103,418 |
| Short-term debt | $383,871 | $694,468 | $460,171 | $251,746 | $11.2M | $10.0M | $4.0M |
| Deferred revenue | $42,405 | $24,404 | $33,058 | — | — | — | — |
| Total current liabilities | $2.9M | $3.1M | $2.2M | $1.1M | $13.0M | $11.1M | $4.7M |
| Long-term debt | $41,313 | $20,180 | $0 | $0 | $160,184 | $53,466 | $0 |
| Lease obligations | $1.0M | $1.3M | $1.6M | $0 | — | — | — |
| Other long-term liabilities | $735,637 | $786,546 | $1.1M | $596,788 | $4.0M | $4.0M | $0 |
| Total liabilities | $3.7M | $3.9M | $3.4M | $1.1M | $17.2M | $15.2M | $4.7M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $31,461 | $106,593 | $65,762 | $58,669 | $18,740 | $18,724 | $18,724 |
| Retained earnings (deficit) | −$68.6M | −$53.6M | −$44.6M | −$36.7M | −$28.5M | −$22.2M | −$14.9M |
| Accumulated other comprehensive income | — | — | — | — | −$4.0M | −$4.0M | −$18,723 |
| Total shareholders' equity | $7.3M | $2.6M | $4.9M | $11.0M | −$15.8M | −$15.1M | −$4.0M |
| Key figures | |||||||
| Total debt | $1.2M | $1.5M | $1.6M | $251,746 | $11.4M | $10.0M | $4.0M |
| Net cash (debt) | $5.3M | −$395,903 | $1.2M | $11.2M | −$10.0M | −$9.9M | −$3.4M |
| Working capital | $4.7M | −$409,807 | $1.7M | $10.8M | −$11.6M | −$11.0M | −$4.1M |
| Tangible book value | $5.2M | $422,411 | $2.6M | $11.0M | −$15.8M | −$15.1M | −$4.0M |
| Current ratio | 2.60 | 0.87 | 1.77 | 10.50 | 0.11 | 0.01 | 0.13 |
| Quick ratio | 2.41 | 0.72 | 1.62 | 10.03 | 0.10 | 0.01 | 0.12 |
| Debt / equity | 0.16 | 0.58 | 0.33 | 0.02 | — | — | — |
| Equity / assets | 66.4% | 39.9% | 59.1% | 90.7% | −1,086.5% | −10,351.9% | −612.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $2.4M | $3.1M | $6.4M | $7.7M | $802,835 | $444,706 | $1.1M | $756,580 | $801,311 | $2.5M | $2.8M | $4.5M |
| Cash & equivalents | $2.4M | $3.1M | $6.4M | $7.7M | $802,835 | $444,706 | $1.1M | $756,580 | $801,311 | $2.5M | $2.8M | $4.5M |
| Receivables | $894,823 | $685,235 | $541,962 | $448,990 | $421,869 | $963,744 | $1.1M | $1.3M | $1.6M | $1.1M | $782,121 | $1.1M |
| Inventory | $82,378 | $77,887 | $53,548 | $35,234 | $43,971 | $38,782 | $27,608 | $25,363 | $29,768 | $9,487 | $18,484 | $9,908 |
| Other current assets | $458,360 | $479,913 | $519,916 | $460,187 | $400,151 | $416,550 | $422,995 | $440,027 | $253,726 | $344,900 | $350,570 | $382,651 |
| Total current assets | $3.9M | $4.3M | $7.6M | $8.6M | $1.7M | $1.9M | $2.7M | $2.5M | $2.7M | $3.9M | $4.0M | $6.0M |
| Property, plant & equipment (net) | $1.6M | $1.5M | $1.3M | $784,073 | $918,977 | $1.5M | $1.6M | $1.8M | $1.7M | $1.9M | $2.0M | $2.2M |
| Goodwill & intangible assets | $2.1M | $2.1M | $2.1M | $2.1M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.0M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $16,709 | $12,816 | $12,815 | $12,815 | $12,814 | $19,675 | $19,676 | $19,676 | $19,675 | $16,059 | $16,060 | $16,059 |
| Total assets | $7.6M | $7.9M | $11.0M | $11.5M | $4.8M | $5.5M | $6.5M | $6.6M | $6.7M | $8.0M | $8.2M | $10.2M |
| Liabilities | ||||||||||||
| Accounts payable | $969,845 | $836,211 | $761,901 | $940,761 | $1.2M | $1.4M | $987,311 | $782,937 | $848,102 | $383,993 | $604,789 | $827,407 |
| Short-term debt | $265,429 | $283,685 | $383,871 | $396,350 | $346,029 | $638,692 | $694,468 | $779,571 | $478,852 | $474,104 | — | $449,145 |
| Deferred revenue | $31,140 | $31,140 | $42,405 | $37,915 | $24,404 | $24,404 | $24,404 | $24,404 | $26,135 | $30,174 | — | $38,250 |
| Total current liabilities | $2.7M | $3.2M | $2.9M | $2.4M | $2.6M | $3.4M | $3.1M | $2.5M | $2.3M | $1.8M | $2.2M | $2.0M |
| Long-term debt | $36,465 | $38,915 | $41,313 | $43,658 | $45,952 | $48,156 | $20,180 | $21,679 | $22,766 | $23,037 | $0 | $0 |
| Lease obligations | $1.4M | $1.3M | $1.0M | $500,894 | $591,099 | $1.2M | $1.3M | $1.4M | $1.4M | $1.5M | $1.6M | $1.7M |
| Other long-term liabilities | $1.1M | $1.1M | $735,637 | $240,940 | $4.3M | $644,314 | $786,546 | $918,146 | $874,280 | $997,588 | $1.1M | $1.2M |
| Total liabilities | $3.9M | $4.3M | $3.7M | $2.6M | $6.9M | $4.1M | $3.9M | $3.4M | $3.2M | $2.8M | $3.4M | $3.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $47,454 | $31,464 | $31,461 | $24,264 | $197,236 | $124,777 | $106,593 | $90,064 | $79,407 | $78,515 | — | $64,535 |
| Retained earnings (deficit) | −$75.6M | −$72.2M | −$68.6M | −$65.4M | −$60.4M | −$56.3M | −$53.6M | −$50.7M | −$48.7M | −$46.6M | −$44.6M | −$42.2M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | — | — | $0 |
| Total shareholders' equity | $3.8M | $3.7M | $7.3M | $8.9M | −$2.1M | $1.4M | $2.6M | $3.1M | $3.4M | $5.3M | $4.9M | $7.0M |
| Key figures | ||||||||||||
| Total debt | $1.4M | $1.4M | $1.2M | $680,948 | $669,997 | $1.3M | $1.5M | $1.7M | $1.4M | $1.5M | — | $1.7M |
| Net cash (debt) | $994,714 | $1.7M | $5.3M | $7.0M | $132,838 | −$886,456 | −$395,903 | −$962,816 | −$574,587 | $958,436 | — | $2.8M |
| Working capital | $1.2M | $1.2M | $4.7M | $6.3M | −$919,478 | −$1.6M | −$409,807 | $57,974 | $354,143 | $2.2M | $1.7M | $4.1M |
| Tangible book value | $1.7M | $1.6M | $5.2M | $6.8M | −$4.3M | −$725,638 | $422,411 | $926,817 | $1.2M | $3.0M | $2.6M | $5.0M |
| Book value per share | $10.82 | $12.22 | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 348K | 300K | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 1.44 | 1.36 | 2.60 | 3.65 | 0.64 | 0.55 | 0.87 | 1.02 | 1.15 | 2.22 | 1.77 | 3.07 |
| Quick ratio | 1.24 | 1.19 | 2.41 | 3.44 | 0.47 | 0.41 | 0.72 | 0.84 | 1.03 | 2.02 | 1.60 | 2.87 |
| Debt / equity | 0.38 | 0.38 | 0.16 | 0.08 | — | 0.92 | 0.58 | 0.55 | 0.40 | 0.28 | — | 0.24 |
| Equity / assets | 49.5% | 46.1% | 66.4% | 77.1% | −45.0% | 25.9% | 39.9% | 47.6% | 51.6% | 65.3% | 59.1% | 68.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 16, 2026); data from EODHD.
BIAF financial position
At the end of fiscal 2025 (December 31, 2025), bioAffinity Technologies had total assets of $11.0 million (up 68.3% from a year earlier), total liabilities of $3.7 million and shareholders' equity of $7.3 million. It held $6.4 million in cash and short-term investments against $1.2 million of debt, a net cash position of $5.3 million. Its current ratio was 2.60. In the latest quarter (ended June 30, 2026) total assets were $7.6 million and equity $3.8 million.
Related: BIAF income statement, BIAF cash flow statement, BIAF key metrics. See the BIAF stock overview for the latest quote and news.
BIAF balance sheet FAQ
What are bioAffinity Technologies's total assets?
bioAffinity Technologies reported total assets of $11.0 million at the end of fiscal 2025 (December 31, 2025), compared with $6.5 million a year earlier.
How much debt does bioAffinity Technologies have?
bioAffinity Technologies had $1.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.16.
How much cash does bioAffinity Technologies have?
bioAffinity Technologies held $6.4 million in cash and short-term investments at the end of fiscal 2025; with $1.2 million of debt that is net cash of $5.3 million.
What is bioAffinity Technologies's book value?
bioAffinity Technologies's shareholders' equity (book value) was $7.3 million at the end of fiscal 2025.
What is bioAffinity Technologies's current ratio?
bioAffinity Technologies had current assets of $7.6 million and current liabilities of $2.9 million, a current ratio of 2.60 (it can cover its short-term obligations).
How much goodwill does bioAffinity Technologies have?
bioAffinity Technologies carried $2.1 million of goodwill and intangible assets, 19.4% of total assets, at the end of fiscal 2025.